Hyperfractionated Radiotherapy
Sponsors
Institut Curie, Maria Sklodowska-Curie National Research Institute of Oncology, Zhejiang Cancer Hospital, Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions
MedulloblastomaNon-Small Cell Lung CancerRectal CancerSmall Cell Lung Cancer Limited Stage
Phase 2
Phase 3
Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4)
CompletedNCT01351870
Start: 2004-04-30End: 2020-03-31Updated: 2025-09-15
Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.
NCT01814969
Start: 2014-03-31End: 2018-12-31Target: 260Updated: 2015-05-05